Products for Research Use Only
RegisterLogin

Povetacicept

CAT: 0804-HY-P990706-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P990706-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Povetacicept (ALPN-303), an Fc fusion protein of an engineered TACI domain, is a dual APRIL/BAFF antagonist. Povetacicept modulates B lymphocytes and pathogenic autoantibodies for the study of Lupus and other B cell-related autoimmune diseases[1][2].
CAS Number
2490217-42-8
Product Name Alternative
ALPN-303
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/povetacicept.html
Purity
99.0
Molecular Weight
(62.61 kDa)
References & Citations
[1]Povetacicept|[2]Evans LS, et al. Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell-Related Autoimmune Diseases. Arthritis Rheumatol. 2023 Jul;75 (7) :1187-1202.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
MBS1580529-01Research Grade Povetacicept
ICH5783-1mgPovetacicept Biosimilar - Research Grade
GTR18695727-01Povetacicept Monoclonal Antibody
A137106Povetacicept Biosimilar (Monoclonal, Tumor Necrosis Factor Receptor superfamily protein TNFRSF13b fusion with IgG1 Fc Fragment.)

Popular Products